Scancell Holdings plc
Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma; and SC134, an antibody for the treatment of small cell lung cancer. It also develops Modi-1, an active peptide immunotherapy that is in phase I… Read more
Scancell Holdings plc (SCNLF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of October 2025: 0.846x
Based on the latest financial reports, Scancell Holdings plc (SCNLF) has a cash flow conversion efficiency ratio of 0.846x as of October 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-7.09 Million) by net assets ($-8.38 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Scancell Holdings plc - Cash Flow Conversion Efficiency Trend (2009–2025)
This chart illustrates how Scancell Holdings plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Scancell Holdings plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Scancell Holdings plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Merafe Resources Limited
F:RZT
|
0.097x |
|
1SPATIAL PLC LS -10
F:G7Z1
|
N/A |
|
A.F.P. Provida
SN:PROVIDA
|
0.022x |
|
Stemmer Imaging AG
XETRA:S9I
|
-0.030x |
|
SWANDEF
NSE:SWANDEF
|
N/A |
|
Renascor Resources Limited
PINK:RSNUF
|
N/A |
|
Chien Shing Harbour Service Co Ltd
TW:8367
|
0.074x |
|
Metalfrio Solutions S.A
SA:FRIO3
|
0.055x |
Annual Cash Flow Conversion Efficiency for Scancell Holdings plc (2009–2025)
The table below shows the annual cash flow conversion efficiency of Scancell Holdings plc from 2009 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-04-30 | $-3.83 Million | $-6.40 Million | 1.669x | -62.65% |
| 2024-04-30 | $-3.50 Million | $-15.66 Million | 4.468x | +242.12% |
| 2023-04-30 | $-6.23 Million | $-8.14 Million | 1.306x | +426.11% |
| 2022-04-30 | $19.48 Million | $-7.80 Million | -0.400x | +35.82% |
| 2021-04-30 | $7.65 Million | $-4.77 Million | -0.624x | +17.16% |
| 2020-04-30 | $9.34 Million | $-7.03 Million | -0.753x | -0.21% |
| 2019-04-30 | $9.34 Million | $-7.02 Million | -0.752x | -157.92% |
| 2018-04-30 | $13.94 Million | $-4.06 Million | -0.291x | +50.77% |
| 2017-04-30 | $6.50 Million | $-3.85 Million | -0.592x | -153.79% |
| 2016-04-30 | $9.99 Million | $-2.33 Million | -0.233x | +40.30% |
| 2015-04-30 | $6.75 Million | $-2.64 Million | -0.391x | -69.41% |
| 2014-04-30 | $9.08 Million | $-2.09 Million | -0.231x | +41.23% |
| 2013-04-30 | $5.09 Million | $-2.00 Million | -0.392x | -418.26% |
| 2012-04-30 | $6.97 Million | $859.62K | 0.123x | +132.17% |
| 2011-04-30 | $4.64 Million | $-1.78 Million | -0.383x | -76.43% |
| 2010-04-30 | $6.05 Million | $-1.31 Million | -0.217x | -7.79% |
| 2009-04-30 | $5.25 Million | $-1.06 Million | -0.202x | -- |